Cargando...
Treatment and Mortality Outcomes in Patients with Other Extrapulmonary Cryptococcal Disease Compared with Central Nervous System Disease
BACKGROUND: Determining the extent of Cryptococcal disease (CD) is key to therapeutic management. Treatment with fluconazole is only recommended for localized pulmonary disease. Induction therapy with amphotericin B (AmB) and flucytosine is recommended for disease at other sites, irrespective of cen...
Gardado en:
| Publicado en: | Mycoses |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7855417/ https://ncbi.nlm.nih.gov/pubmed/33065769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/myc.13199 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|